Pharsight

Drugs that contain Ixazomib Citrate

1. Ninlaro patents expiration

NINLARO's oppositions filed in EPO
Can you believe NINLARO received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8546608 TAKEDA PHARMS USA Proteasome inhibitors and methods of using the same
Aug, 2024

(2 months from now)

US8003819 TAKEDA PHARMS USA Proteasome inhibitors
Aug, 2027

(3 years from now)

US8530694 TAKEDA PHARMS USA Proteasome inhibitors
Aug, 2027

(3 years from now)

US7687662 TAKEDA PHARMS USA Proteasome inhibitors
Aug, 2027

(3 years from now)

US8859504 TAKEDA PHARMS USA Boronate ester compounds and pharmaceutical compositions thereof
Jun, 2029

(5 years from now)

US7442830 TAKEDA PHARMS USA Proteasome inhibitors
Nov, 2029

(5 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9233115 TAKEDA PHARMS USA Proteasome inhibitors and methods of using the same
Aug, 2024

(2 months from now)

US8871745 TAKEDA PHARMS USA Proteasome inhibitors
Aug, 2027

(3 years from now)

US9175017 TAKEDA PHARMS USA Boronate ester compounds and pharmaceutical compositions thereof
Jun, 2029

(5 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Nov 20, 2020
Orphan Drug Exclusivity(ODE) Nov 20, 2022
Orphan Drug Exclusivity(ODE-103) Nov 20, 2022

NCE-1 date: 21 November, 2019

Market Authorisation Date: 20 November, 2015

Treatment: Use in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy

Dosage: CAPSULE;ORAL

How can I launch a generic of NINLARO before it's drug patent expiration?
More Information on Dosage

NINLARO family patents

Family Patents